-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 WICYtfcwFF+tWwTLXTQSUZsI4Hj6p/IURH6Kf6TFldWE70v2Fy3SNfn+OjR4LGAa
 m3/Uxww0UwLAqrdX8hCZTQ==

<SEC-DOCUMENT>0001181431-09-024548.txt : 20090513
<SEC-HEADER>0001181431-09-024548.hdr.sgml : 20090513
<ACCEPTANCE-DATETIME>20090513123103
ACCESSION NUMBER:		0001181431-09-024548
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20090505
FILED AS OF DATE:		20090513
DATE AS OF CHANGE:		20090513

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Simon Lee S
		CENTRAL INDEX KEY:			0001362764

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15313
		FILM NUMBER:		09821329

	MAIL ADDRESS:	
		STREET 1:		35 OLDHAM ROAD
		CITY:			WEST NEWTON
		STATE:			MA
		ZIP:			02465

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SAVIENT PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000722104
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				133033811
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		ONE TOWER CENTER
		CITY:			EAST BRUNSWICK
		STATE:			NJ
		ZIP:			08816
		BUSINESS PHONE:		7324189300

	MAIL ADDRESS:	
		STREET 1:		ONE TOWER CENTER
		CITY:			EAST BRUNSWICK
		STATE:			NJ
		ZIP:			08816

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIO TECHNOLOGY GENERAL CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rrd242439.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2009-05-05</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000722104</issuerCik>
        <issuerName>SAVIENT PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>SVNT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001362764</rptOwnerCik>
            <rptOwnerName>Simon Lee S</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>SAVIENT PHARMACEUTICALS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>ONE TOWER CENTER, 14TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>EAST BRUNSWICKI</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>08816</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock, $.01 par value per share</value>
            </securityTitle>
            <transactionDate>
                <value>2009-05-05</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>7448</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>5.37</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>20374</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Option to Purchase Common Stock, $0.01 par value</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>5.37</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2009-05-05</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F2"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>10486</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>5.37</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2009-08-05</value>
            </exerciseDate>
            <expirationDate>
                <value>2019-05-05</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, $0.01 par value</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>10486</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>10486</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The right to receive these shares is pursuant to a restricted stock grant that vests equally every three months beginning on August 5, 2009, with the last tranche vesting on the earlier of May 5, 2010 or the Company's 2010 Annual Meeting of Stockholders.</footnote>
        <footnote id="F2">These stock options will vest equally every three months beginning on August 5, 2009, with the last tranche vesting on the earlier of May 5, 2010 or the Company's 2010 Annual Meeting of Stockholders.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Irina Azer as Attorney-In-Fact for</signatureName>
        <signatureDate>2009-05-13</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----